Related Experiment Video
Updated: Jul 27, 2025

10:12
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
2.1K
A Brief Guide to Preparing a Peptide-Drug Conjugate
1Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124, Parma, Italy.
Chembiochem : a European Journal of Chemical Biology
|June 8, 2023
Summary
Peptide-drug conjugates (PDCs) offer new possibilities for targeted therapy and early disease diagnosis. This paper guides the selection of optimal conjugation reactions for synthesizing novel PDCs, considering reaction conditions and linker stability.
Area of Science:
- Medicinal Chemistry
- Drug Delivery Systems
- Bioconjugation Chemistry
Background:
- Peptide-drug conjugates (PDCs) are hybrid molecules combining targeting peptides with therapeutic payloads.
- PDCs show promise in targeted therapy and early disease diagnosis.
- The synthesis of PDCs relies heavily on efficient and specific conjugation strategies.
Purpose of the Study:
- To provide a concise guide for selecting the most effective conjugation reaction in PDC synthesis.
- To compare common and efficient conjugation methods based on literature data.
- To aid researchers in planning the synthesis of novel peptide-drug conjugates.
Main Methods:
- Systematic review and comparison of reported PDC conjugation methods.
- Analysis of reaction conditions, linker stability, and associated advantages/disadvantages.
- Literature-based evaluation of conjugation strategies for PDCs.
Main Results:
- Identification of key factors influencing conjugation efficiency and success.
- Comparison of various conjugation techniques, highlighting their pros and cons.
- Overview of prevalent and effective conjugation strategies in recent PDC literature.
Conclusions:
- The choice of conjugation reaction is critical for successful PDC synthesis.
- Understanding reaction conditions and linker properties is essential for optimizing PDC development.
- This guide serves as a valuable resource for researchers developing novel peptide-drug conjugates.
Related Concept Videos
Phase II Conjugation Reactions: Overview
250
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
250
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
304
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
304

